A state-of-the-art technology developed by an expert from Hong Kong allows drug screening and discovery using a human heart-in-a-jar with genetic and immunologic make-up identical to the individual source.
A US FDA-approved ring oximeter developed by a start-up in Hong Kong enables screening of obstructive sleep apnoea (OSA) at home and can be used for treatment monitoring to enhance patients’ adherence.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Pharmacist - Malaysia digital copy today!
Interim results of REGENERATE* trial highlight the ability of experimental noninvasive tests to evaluate treatment response in adults with NASH** and advanced liver fibrosis who are receiving obeticholic acid (OCA).
The combination of pitavastatin and fenofibrate appears to have superior effect on non-high-density lipoprotein cholesterol (non–HDL-C), as well as other lipids, compared with a statin alone in high-risk patients with mixed dyslipidemia, according to a study.
The use of aspirin for primary prevention in patients without known cardiovascular diseases (CVDs) significantly reduces the risk of myocardial infarction (MI) but increases that of major bleeding and haemorrhagic stroke, according to a meta-analysis.